{"id":"https://openalex.org/W4387980346","doi":"https://doi.org/10.1183/13993003.congress-2023.pa596","title":"Characterization of a corticosteroid-resistant inflammatory model of human bronchial epithelial cells cultured at air-liquid interface","display_name":"Characterization of a corticosteroid-resistant inflammatory model of human bronchial epithelial cells cultured at air-liquid interface","publication_year":2023,"publication_date":"2023-09-09","ids":{"openalex":"https://openalex.org/W4387980346","doi":"https://doi.org/10.1183/13993003.congress-2023.pa596"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2023.pa596","doi":"https://doi.org/10.1183/13993003.congress-2023.pa596","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2023.pa596","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030485387","display_name":"Stefano Marchesi","orcid":"https://orcid.org/0000-0003-3973-133X","observed_orcids":["https://orcid.org/0000-0003-3973-133X"]},"institutions":[{"id":"https://openalex.org/I4210114103","display_name":"IFOM","ror":"https://ror.org/02hcsa680","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210114103"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefano Marchesi","raw_affiliation_strings":["IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy","institution_ids":["https://openalex.org/I4210114103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042946289","display_name":"Elisa Schiavi","orcid":"https://orcid.org/0009-0008-6516-263X","observed_orcids":["https://orcid.org/0009-0008-6516-263X"]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elisa Schiavi","raw_affiliation_strings":["Corporate Pre-Clinical R&D CHIESI FARMACEUTICI S.p.A., Parma (PR), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corporate Pre-Clinical R&D CHIESI FARMACEUTICI S.p.A., Parma (PR), Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068174660","display_name":"Andrea Disanza","orcid":"https://orcid.org/0000-0001-5101-2907","observed_orcids":["https://orcid.org/0000-0001-5101-2907"]},"institutions":[{"id":"https://openalex.org/I4210114103","display_name":"IFOM","ror":"https://ror.org/02hcsa680","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210114103"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Disanza","raw_affiliation_strings":["IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy","institution_ids":["https://openalex.org/I4210114103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023992476","display_name":"Leonardo Barzaghi","orcid":"https://orcid.org/0000-0002-3174-6441","observed_orcids":["https://orcid.org/0000-0002-3174-6441"]},"institutions":[{"id":"https://openalex.org/I4210114103","display_name":"IFOM","ror":"https://ror.org/02hcsa680","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210114103"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Leonardo Barzaghi","raw_affiliation_strings":["IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy","institution_ids":["https://openalex.org/I4210114103"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Massimiliano Bonanni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Massimiliano Bonanni","raw_affiliation_strings":["Bio4Life, Parma (PR), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bio4Life, Parma (PR), Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036132330","display_name":"Giorgio Scita","orcid":"https://orcid.org/0000-0001-7984-1889","observed_orcids":["https://orcid.org/0000-0001-7984-1889"]},"institutions":[{"id":"https://openalex.org/I4210114103","display_name":"IFOM","ror":"https://ror.org/02hcsa680","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210114103"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giorgio Scita","raw_affiliation_strings":["IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy","institution_ids":["https://openalex.org/I4210114103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087386233","display_name":"Fabrizio Facchinetti","orcid":"https://orcid.org/0000-0003-3505-4159","observed_orcids":["https://orcid.org/0000-0003-3505-4159"]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fabrizio Facchinetti","raw_affiliation_strings":["Corporate Pre-Clinical R&D CHIESI FARMACEUTICI S.p.A., Parma (PR), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corporate Pre-Clinical R&D CHIESI FARMACEUTICI S.p.A., Parma (PR), Italy","institution_ids":["https://openalex.org/I4210162628"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA596","last_page":"PA596"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.6309000253677368,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.6309000253677368,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.301800012588501,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.013899999670684338,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/steroid-resistance","display_name":"steroid resistance","score":0.9879999756813049},{"id":"https://openalex.org/keywords/airway-inflammation","display_name":"airway inflammation","score":0.652999997138977},{"id":"https://openalex.org/keywords/bronchial-epithelial-cells","display_name":"bronchial epithelial cells","score":0.9100000262260437},{"id":"https://openalex.org/keywords/air-liquid-interface-culture","display_name":"air-liquid interface culture","score":0.9179999828338623},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":0.9229999780654907},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8880000114440918},{"id":"https://openalex.org/keywords/budesonide","display_name":"budesonide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.7960000038146973},{"id":"https://openalex.org/keywords/chemokines","display_name":"chemokines","score":0.6809999942779541},{"id":"https://openalex.org/keywords/cytokine-expression","display_name":"cytokine expression","score":0.6110000014305115},{"id":"https://openalex.org/keywords/connexins","display_name":"connexins","score":0.8629999756813049},{"id":"https://openalex.org/keywords/transepithelial-electrical-resistance","display_name":"transepithelial electrical resistance","score":0.972000002861023},{"id":"https://openalex.org/keywords/ciliary-beating","display_name":"ciliary beating","score":0.7020000219345093},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.7289999723434448},{"id":"https://openalex.org/keywords/anti-inflammatory-drug-testing","display_name":"anti-inflammatory drug testing","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.8075901865959167},{"id":"https://openalex.org/C96525457","wikidata":"https://www.wikidata.org/wiki/Q5014879","display_name":"CXCL1","level":4,"score":0.7311639189720154},{"id":"https://openalex.org/C68324877","wikidata":"https://www.wikidata.org/wiki/Q421859","display_name":"Interleukin 8","level":3,"score":0.6909158229827881},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.6631538271903992},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5852009057998657},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.5650463104248047},{"id":"https://openalex.org/C116484652","wikidata":"https://www.wikidata.org/wiki/Q3492926","display_name":"CCL5","level":5,"score":0.5343809127807617},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.48642706871032715},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4804372489452362},{"id":"https://openalex.org/C7806222","wikidata":"https://www.wikidata.org/wiki/Q5014889","display_name":"CXCL5","level":4,"score":0.4797762334346771},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3635336756706238},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33913201093673706},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.225290447473526},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.15328100323677063},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.08648735284805298},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2023.pa596","doi":"https://doi.org/10.1183/13993003.congress-2023.pa596","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2023.pa596","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416635811","https://openalex.org/W6987045289","https://openalex.org/W2113370135","https://openalex.org/W2131169079","https://openalex.org/W2117514686","https://openalex.org/W4229442015","https://openalex.org/W2077939691","https://openalex.org/W2030992168","https://openalex.org/W2005492466","https://openalex.org/W2971255779"],"abstract_inverted_index":{"IL-17-driven":[0],"inflammation":[1],"and":[2,55,86,120,128,135,146,161,169,186,217],"increased":[3],"levels":[4],"of":[5,26,49,69,95,125,152,174,213],"TNF\u03b1":[6,56,87,121,147,170,187],"have":[7],"been":[8],"linked":[9],"to":[10,53,57,78,114],"pulmonary":[11],"inflammatory":[12,211],"conditions":[13],"associated":[14],"with":[15,137,229],"corticosteroid":[16,72],"resistance":[17,177],"such":[18,130,156],"as":[19,131,157],"COPD.":[20],"Physiologically":[21],"relevant":[22],"in":[23,66,190,192,224,227],"vitro":[24],"models":[25],"bronchial":[27,61],"epithelial":[28,62],"cells":[29],"cultured":[30],"at":[31],"air-liquid":[32],"interface":[33],"(ALI)":[34],"are":[35],"becoming":[36],"a":[37,79,92,172,209],"tool":[38],"for":[39,76,109,220],"testing":[40,221],"inhaled":[41,71],"anti-inflammatory":[42,222],"agents.":[43],"This":[44],"study":[45],"investigates":[46],"the":[47,50,67,70,110,123,139,149,158,204,214],"effect":[48,164],"combined":[51],"exposure":[52,75],"IL-17":[54,84,119,145,168,185],"ALI":[58],"human":[59],"normal":[60],"cell":[63],"cultures":[64],"(MucilAir\u2122)":[65],"presence":[68],"budesonide.":[73,117,144,167,182,201],"Upon":[74],"24h":[77],"pro-inflammatory":[80],"stimulus":[81],"composed":[82],"by":[83,116,143,166,181,200],"(30ng/ml)":[85],"(30":[88],"ng/ml),":[89],"we":[90],"detected":[91],"marked":[93],"upregulation":[94],"various":[96],"cytokines":[97,127],"mRNA":[98,150],"including":[99],"CCL20,":[100],"CCL22,":[101,132],"CSF2,":[102],"CCL2,":[103,136],"IL-1\u03b2,":[104],"CXCL1,":[105],"CXCL8,":[106],"which":[107,196],"were,":[108],"most":[111],"part,":[112],"resistant":[113],"modulation":[115],"Moreover,":[118],"induced":[122,148],"release":[124],"several":[126],"chemokines,":[129],"CCL5,":[133],"CSF2":[134],"only":[138],"latter":[140],"being":[141],"modulated":[142,165],"expression":[151],"some":[153],"structural":[154],"genes":[155],"connexins":[159],"GJB2":[160],"GJA1,":[162],"an":[163],"caused":[171],"decreased":[173],"transepithelial":[175],"electrical":[176],"(TEER)":[178],"not":[179,198],"counteracted":[180],"In":[183,202],"addition,":[184],"stimulation":[188],"resulted":[189],"decrease":[191],"cilia":[193],"beating":[194],"frequency,":[195],"was":[197],"rescued":[199],"sum,":[203],"model":[205],"here":[206],"described":[207],"mimics":[208],"corticosteroid-resistant":[210],"condition":[212],"airway":[215],"epithelium":[216],"is":[218],"suitable":[219],"drugs":[223],"comparison":[225],"and/or":[226],"combination":[228],"corticosteroids.":[230]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-10-28T00:00:00"}